Zofia E. Dziewanowska
Profile
Zofia E.
Dziewanowska held several high-ranking positions in the pharmaceutical industry, including Vice President of Clinical Research at Ligand Pharmaceuticals and Senior Vice President of Global Clinical Research and Development at Cypros Pharmaceutical Corp.
She also served as Vice Chairman of the Medical Section Steering Committee at the Pharmaceutical Research & Manufacturers of America and Chairman of the Education Committee at the American Academy of Pharmaceutical Physicians.
Prior to her industry career, she earned doctorates from Warsaw University of Technology, the University of Warsaw, and the Polish Academy of Sciences.
Former positions of Zofia E. Dziewanowska
Companies | Position | End |
---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 31/12/2008 |
Cypros Pharmaceutical Corp. | Chief Tech/Sci/R&D Officer | 20/09/2007 |
MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 31/12/1993 |
American Academy of Pharmaceutical Physicians | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Corporate Officer/Principal | - |
Training of Zofia E. Dziewanowska
Warsaw University of Technology | Doctorate Degree |
University of Warsaw | Doctorate Degree |
Polish Academy of Sciences | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 6 |
---|---|
Cypros Pharmaceutical Corp. | Health Technology |
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
American Academy of Pharmaceutical Physicians |
- Stock Market
- Insiders
- Zofia E. Dziewanowska